A2780-GFP
USD 800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Información general
| Descripción | A2780-GFP is a genetically modified derivative of the human ovarian carcinoma cell line A2780, engineered to stably express green fluorescent protein (GFP). The parental A2780 cell line was established from an ovarian tumor in an adult patient and is widely used as a model for epithelial ovarian cancer, particularly in studies of chemotherapy response. It is known for its relative sensitivity to platinum-based agents such as cisplatin, making it a valuable system for investigating mechanisms of drug action and resistance. The GFP-expressing variant preserves these biological characteristics while incorporating a fluorescent reporter for enhanced experimental utility. The stable expression of GFP enables real-time visualization and quantitative analysis of A2780-GFP cells in a variety of experimental settings. Fluorescence-based detection allows researchers to monitor cell proliferation, morphology, migration, and viability in vitro, as well as to track tumor growth and dissemination in vivo. This is particularly advantageous in xenograft and metastasis models, where GFP facilitates discrimination of tumor cells from surrounding host tissue. The fluorescent signal is generally stable across passages, although expression levels may vary depending on the transduction method and clonal selection. A2780-GFP retains the core molecular and phenotypic features of the parental A2780 line, including pathways associated with DNA damage response, apoptosis, and chemotherapeutic sensitivity. As such, it is commonly used in high-content imaging assays, drug screening platforms, and co-culture systems where spatial and temporal resolution of tumor cell behavior is required. The addition of GFP significantly enhances the versatility of this model, supporting applications in ovarian cancer research, therapeutic evaluation, and studies of tumor cell dynamics. |
|---|---|
| Organismo | Human |
| Tejido | Ovary |
| Enfermedad | Ovarian endometrioid adenocarcinoma |
| Lugar de metástasis | Primary tumor site (ovary) |
| Aplicaciones | Ovarian cancer imaging; GFP-based tumor tracking; in vivo fluorescence imaging; combination with parental A2780 for comparative studies; drug efficacy visualization |
Características
| Edad | Age unspecified |
|---|---|
| Género | Female |
| Origen étnico | African American |
| Morfología | Epithelial-like |
| Tipo de célula | Epithelial cells |
| Propiedades de crecimiento | Adherent |
Datos normativos
| Referencia | A2780-GFP (Cytion catalog number 305676) |
|---|---|
| Nivel de bioseguridad | 1 |
| NCBI_TaxID | 9606 |
| N.º de acceso de Cellosaurus | Not assigned (A2780-GFP reporter derivative; parental A2780 CVCL_1099) |
| Estado de los OGM | GMO-S1: This human A2780 ovarian cancer line contains a lentiviral GFP expression construct for fluorescence-based imaging. This classification applies only within Germany and may differ elsewhere. |
Datos biomoleculares
| Expresión de antígenos | GFP |
|---|
Manejo
| Medio de cultivo | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Suplementos | Supplement the medium with 10% FBS |
| Reactivo de disociación | Accutase |
| Relación de división | 1 to 5 |
| Densidad de siembra | 1 to 3 × 10⁴ cells/cm² |
| Renovación de fluidos | 2 to 3 times per week |
| Medio de congelación | As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability. |
| Descongelación y cultivo de células |
|
| Atmósfera de incubación | 37°C, 5% CO2, humidified atmosphere. |
| Condiciones de envío | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condiciones de almacenamiento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Control de calidad y análisis molecular
Certificado de análisis (CoA)
| Número de lote | Tipo de certificado | Fecha | Número de catálogo |
|---|---|---|---|
| 305676-040326 | Certificado de análisis | 08. Apr. 2026 | 305676 |